| Original language | English |
|---|---|
| Journal | Expert Opinion on Pharmacotherapy |
| DOIs | |
| Publication status | Published - Jan 1 2019 |
Keywords
- bremelanotide
- DHEA
- female sexual dysfunctions (FSDs)
- flibanserin
- hypoactive sexual desire disorder (HSDD)
- ospemifene
- Sexual education
- vulvovaginal atrophy/genitourinary syndrome of menopause (VVA/GSM)
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
Cite this
What are the challenges in prescribing pharmacotherapy for female sexual dysfunctions? / Nappi, Rossella E.; Gardella, Barbara.
In: Expert Opinion on Pharmacotherapy, 01.01.2019.Research output: Contribution to journal › Editorial
}
TY - JOUR
T1 - What are the challenges in prescribing pharmacotherapy for female sexual dysfunctions?
AU - Nappi, Rossella E.
AU - Gardella, Barbara
PY - 2019/1/1
Y1 - 2019/1/1
KW - bremelanotide
KW - DHEA
KW - female sexual dysfunctions (FSDs)
KW - flibanserin
KW - hypoactive sexual desire disorder (HSDD)
KW - ospemifene
KW - Sexual education
KW - vulvovaginal atrophy/genitourinary syndrome of menopause (VVA/GSM)
UR - http://www.scopus.com/inward/record.url?scp=85062320013&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062320013&partnerID=8YFLogxK
U2 - 10.1080/14656566.2019.1582644
DO - 10.1080/14656566.2019.1582644
M3 - Editorial
AN - SCOPUS:85062320013
JO - Expert Opinion on Pharmacotherapy
JF - Expert Opinion on Pharmacotherapy
SN - 1465-6566
ER -